Navigation

Summary of Results

Health Topic:   Cancer
Guidance:   Multiple myeloma - bortezomib
Description:   The summary of the published technology appraisal on Multiple myeloma - bortezomib. It links to the published guidance and key documents.

NICE implementation uptake reports

Implementation uptake report Assessment Published Date Coverage

External literature

External literature Assessment Coverage

Leukaemia Care (2009) 2009 Haematology Survey

Description: A survey examining the extent to which NICE guidance (bortezomib and rituximab) is being implemented, and how and when PCTs are making treatments available to patients in England and Wales. The study found that only 60% of PCTs and 35% of LHBs said they fund these treatments routinely

Doubts about or mixed impact in practice National

All Wales Medicines Strategy Group (2011) Monitoring of AWMSG recommendations

Description: This paper covers medicines that have been recommended by the All Wales Medicines Strategy Group (AWMSG) for use in NHS Wales. Five of these medicines, Adalimumab, Teriparatide, Topotecan Hydrochloride, Bortezomib and Docetaxel are also covered by a NICE Technology Appraisal. The report includes hospital and homecare usage data for three of these drugs, Adalimumab, Teriparatide, Topotecan Hydrochloride.

Not graded Regional

Richards, M (2010) Extent and causes of international variation in drug usage: A report for the Secretary of State for Health by Professor Sir Mike Richards CBE

Description: This report looks at medicines usage between countries, using IMS Health data. The WHO defined daily dose or the maximum or prescribed daily dose was used to measure usage. Results rank the UK relative to other countries usage and present calculations showing how close or otherwise the UK is to the average use across groups of other countries. It should be noted that countries other than the UK would not be expected to adhere to NICE guidance making comparisons between countries not possible.

Not graded National

This page was last updated: 03 March 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.